HACKENSACK, N.J., Sept. 6, 2016 /PRNewswire/ -- Champions Oncology
(NASDAQ: CSBR), a company engaged in the development of advanced
technology solutions and services to personalize the development
and use of oncology drugs, today announced it will report its
financial and operational results for the first quarter ended
July 31, 2016, on Friday, September 9, 2016, before market
open.
The company will host a conference call to discuss the results
that day at 8:30 a.m. EDT
(5:30 a.m. PDT). To participate in
the call, please call 800-875-3456 (domestic), 800-648-0973
(Canadian Toll Free) or 302-607-2001 (international) ten minutes
ahead of the call and give the verbal passcode "Champions".
An MP3 recoding of the call will be available on the Investor
tab of the company's website within 72 hours.
About Champions Oncology
Champions Oncology, Inc. is engaged in the development of
advanced technology solutions and services to personalize the
development and use of oncology drugs. The company's technology
platform is a novel approach to personalizing cancer care based
upon the implantation of primary human tumors in immune-deficient
mice to create TumorGrafts that preserve the biological
characteristics of the original human tumor in order to determine
the efficacy of a treatment regimen. The company uses this
technology in conjunction with related services to offer solutions
for two customer groups: Personalized Oncology Solutions, in which
results help guide the development of personalized treatment plans,
and Translational Oncology Solutions, in which pharmaceutical and
biotechnology companies seeking personalized approaches to drug
development can lower the cost and increase the speed of developing
new drugs. For more information, please
visit www.championsoncology.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/champions-oncology-to-announce-first-quarter-financial-results-on-friday-september-9-2016-300322485.html
SOURCE Champions Oncology